Kymera Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $102M | 4.0M | 25.46 |
| 2023-09-30 | $55M | 3.9M | 13.90 |
| 2023-06-30 | $86M | 3.7M | 22.99 |
| 2023-03-31 | $111M | 3.7M | 29.63 |
| 2022-12-31 | $91M | 3.7M | 24.96 |
| 2022-06-30 | $57M | 2.9M | 19.69 |
| 2022-03-31 | $120M | 2.8M | 42.32 |
| 2021-09-30 | $170M | 2.9M | 58.74 |
| 2021-06-30 | $99M | 2.0M | 48.49 |
| 2021-03-31 | $67M | 1.7M | 38.84 |
| 2020-12-31 | $39M | 623k | 62.03 |
| 2020-09-30 | $15M | 466k | 32.31 |